What began as four friends carrying hard drives through Amsterdam dorms is now a global platform serving millions. But the ...

The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...

A new study found that smoking as few as two cigarettes a day can significantly increase a person’s risk of cardiovascular ...

NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF) (“NervGen” or the “Company”), a clinical-stage biopharmaceutical company ...

The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...

Come again? The infamous little blue pill that keeps men up and at ’em may improve a different kind of hardness — hardness of ...

Professor Lauryn DeGreeff's study, published in Frontiers, finds bomb-sniffing dogs often miss targets due to limited training resources, not unrealistic standards.

A new randomized trial from North Carolina suggests that digital tools like mPATH may slightly boost participation in CT lung ...

More than 22 million people, many of them children, could die preventable deaths by 2030 due to aid cuts by the United States ...

New AI system helps scientists rapidly pinpoint the most promising paths to an HIV vaccine. view more . Credit: Scripps ...

Good morning and welcome, everyone, to today's press briefing from the U.S. Department of State's Africa Media Hub. Today, we are discussing the America First Global Health Strategy and the U.S.

SHELTON, CONNECTICUT / ACCESS Newswire / November 14, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...